Dengue Virus Diagnostic Tests Market

Dengue is a mosquito-borne disease caused by the dengue viruses. It is a vector-borne highly communicable disease. There are four distinct but related virus serotypes all of which can cause dengue fever or the more serious forms of the disease, dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS).
Dengue Virus Diagnostic Tests Market aims to provide a comprehensive presentation of the global market for Dengue Virus Diagnostic Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dengue Virus Diagnostic Tests. Dengue Virus Diagnostic Tests Market contains market size and forecasts of Dengue Virus Diagnostic Tests in global, including the following market information:
Global Dengue Virus Diagnostic Tests Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Dengue Virus Diagnostic Tests market was valued at US$ 3344.4 million in 2022 and is projected to reach US$ 4251.7 million by 2029, at a CAGR of 3.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Dengue NS1Ag Test Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Dengue Virus Diagnostic Tests include Alere, Biogate, NovaBios Laboratories Diagnostics, Rapikit, Wondfo, BTNX, GENESIS, Boson Biotech and Adaltis, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Dengue Virus Diagnostic Tests companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dengue Virus Diagnostic Tests Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Dengue Virus Diagnostic Tests Market Segment Percentages, by Type, 2022 (%)
Dengue NS1Ag Test
Dengue IgG/IgM Test
Dengue NS1 Ag-IgG/IgM Test
Global Dengue Virus Diagnostic Tests Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Dengue Virus Diagnostic Tests Market Segment Percentages, by Application, 2022 (%)
Hospital
Research Institution
Others
Global Dengue Virus Diagnostic Tests Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Dengue Virus Diagnostic Tests Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dengue Virus Diagnostic Tests revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Dengue Virus Diagnostic Tests revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alere
Biogate
NovaBios Laboratories Diagnostics
Rapikit
Wondfo
BTNX
GENESIS
Boson Biotech
Adaltis
AccuBio Tech
Mediven
NTBIO
Outline of Major Chapters:
Chapter 1: Introduces the definition of Dengue Virus Diagnostic Tests, market overview.
Chapter 2: Global Dengue Virus Diagnostic Tests market size in revenue.
Chapter 3: Detailed analysis of Dengue Virus Diagnostic Tests company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Dengue Virus Diagnostic Tests in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.